Liu Yanjun, Ren Xiang, Fan Chao, Wu Wenzhong, Zhang Wei, Wang Yanwen
INNOBIO Corporation Limited, No. 49, DDA, Dalian 116600, China.
DeOxiTech Consulting, 30 Cloverfield Court, Dartmouth, NS B2W 0B3, Canada.
Foods. 2022 Jun 25;11(13):1883. doi: 10.3390/foods11131883.
Today's consumers are increasingly aware of the beneficial effects of n-3 PUFA in preventing, delaying, and intervening various diseases, such as coronary artery disease, hypertension, diabetes, inflammatory and autoimmune disorders, neurodegenerative diseases, depression, and many other ailments. The role of n-3 PUFA on aging and cognitive function is also one of the hot topics in basic research, product development, and clinical applications. For decades, n-3 PUFA, especially EPA and DHA, have been supplied by fish oil and seafood. With the continuous increase of global population, awareness about the health benefits of n-3 PUFA, and socioeconomic improvement worldwide, the supply chain is facing increasing challenges of insufficient production. In this regard, microalgae have been well considered as promising sources of n-3 PUFA oil to mitigate the supply shortages. The use of microalgae to produce n-3 PUFA-rich oils has been explored for over two decades and some species have already been used commercially to produce n-3 PUFA, in particular EPA- and/or DHA-rich oils. In addition to n-3 PUFA, microalgae biomass contains many other high value biomolecules, which can be used in food, dietary supplement, pharmaceutical ingredient, and feedstock. The present review covers the health benefits of n-3 PUFA, EPA, and DHA, with particular attention given to the various approaches attempted in the nutritional interventions using EPA and DHA alone or combined with other nutrients and bioactive compounds towards improved health conditions in people with mild cognitive impairment and Alzheimer's disease. It also covers the applications of microalgae n-3 PUFA in food and dietary supplement sectors and the economic and environmental sustainability of using microalgae as a platform for n-3 PUFA-rich oil production.
如今的消费者越来越意识到n-3多不饱和脂肪酸(PUFA)在预防、延缓和干预各种疾病方面的有益作用,这些疾病包括冠状动脉疾病、高血压、糖尿病、炎症和自身免疫性疾病、神经退行性疾病、抑郁症以及许多其他疾病。n-3 PUFA对衰老和认知功能的作用也是基础研究、产品开发和临床应用中的热点话题之一。几十年来,n-3 PUFA,尤其是二十碳五烯酸(EPA)和二十二碳六烯酸(DHA),一直由鱼油和海鲜提供。随着全球人口的持续增长、对n-3 PUFA健康益处的认识以及全球社会经济的改善,供应链正面临着产量不足的日益严峻挑战。在这方面,微藻已被充分视为有前景的n-3 PUFA油来源,以缓解供应短缺问题。利用微藻生产富含n-3 PUFA的油已经探索了二十多年,一些物种已经在商业上用于生产n-3 PUFA,特别是富含EPA和/或DHA的油。除了n-3 PUFA,微藻生物质还含有许多其他高价值生物分子,可用于食品、膳食补充剂、药物成分和原料。本综述涵盖了n-3 PUFA、EPA和DHA的健康益处,特别关注了在营养干预中单独使用EPA和DHA或与其他营养素和生物活性化合物联合使用以改善轻度认知障碍和阿尔茨海默病患者健康状况的各种方法。它还涵盖了微藻n-3 PUFA在食品和膳食补充剂领域的应用,以及将微藻作为富含n-3 PUFA油生产平台的经济和环境可持续性。